The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy
Hui Wu(Jishou University), Haiping Jiang(Zhejiang Chinese Medical University)
Cited by 0
Related Papers
Biomarkers of aging
|Science China Life Sciences|2023|362
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234
GeneCompass: deciphering universal gene regulatory mechanisms with a knowledge-informed cross-species foundation model
|Cell Research|2024|104
Novel immunological and nutritional-based prognostic index for gastric cancer
|World Journal of Gastroenterology|2015|101